Cost Effectiveness Analysis of Varenicline Use for Smoking Cessation in the City of São Paulo From the Public Health System Perspective

Value in Health - United Kingdom
doi 10.1016/j.jval.2014.03.1029
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Cost-Effectiveness of Alternative Smoking Cessation Scenarios in Spain: Results From the EQUIPTMOD

Addiction
MedicinePsychiatryMental Health
2018English

Effectiveness of Varenicline and Counselling for Smoking Cessation in an Observational Cohort Study in China

BMJ Open
Medicine
2016English

Cost-Effectiveness of Varenicline Compared to Placebo as an Aid to Smoking Cessation in Patients With Cardiovascular Disease

The Open Pharmacoeconomics & Health Economics Journal
2012English

The Effectiveness, Safety and Cost-Effectiveness of Cytisine Versus Varenicline for Smoking Cessation in an Australian Population: A Study Protocol for a Randomised Controlled Non-Inferiority Trial

Addiction
MedicinePsychiatryMental Health
2019English

Analysis of Work and Problems in the Provision of Smoking Cessation in Counseling Centers for Smoking Cessation at the Regional Public Health Authorities in the Slovak Republic

Hygiena
EnvironmentalPublic HealthOccupational Health
2018English

Cost Variation of Antipsychotics in the Public Health System in Brazil: The Implication for Health Resource Use

Jornal Brasileiro de Economia da Saúde
2017English

Public Health Nursing Acceptance of the 5 A's Protocol for Prenatal Smoking Cessation

Californian Journal of Health Promotion
2004English

The Cost to Society of Smoking Cessation

Thorax
PulmonaryRespiratory Medicine
1998English

Evaluation of Varenicline Usage on Ventricular Repolarization After Smoking Cessation

Annals of Noninvasive Electrocardiology
MedicineCardiovascular MedicinePhysiologyCardiology
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy